Use of antimicrobial catheter lock solutions to prevent catheter-related bacteremia

Clinical Journal of the American Society of Nephrology

Volumn 2, Issue 5, 2007, Pages 1073-1078

  Bleyer, Anthony J ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

BACTEREMIA; CATHETERIZATION; EQUIPMENT; HUMAN; RENAL REPLACEMENT THERAPY; REVIEW; SOLUTION AND SOLUBILITY;

ANTI-BACTERIAL AGENTS; BACTEREMIA; CATHETERIZATION; EQUIPMENT CONTAMINATION; HUMANS; RENAL DIALYSIS; SOLUTIONS;

EID: 34548822177     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.00290107     Document Type: Review

References (34)

1. Lok CE, Stanley KE, Hux JE, Richardson R, Tobe SW, Conly J: Hemodialysis infection prevention with polysporin ointment. J Am Soc Nephrol 14: 169-179, 2003
2. McIntyre CW, Hulme LJ, Taal M, Fluck RJ: Locking of tunneled hemodialysis catheters with gentamicin and heparin. Kidney Int 66: 801-805, 2004
3. Dogra GK, Herson H, Hutchison B, Irish AB, Heath CH, Golledge C, Luxton G, Moody H: Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study. J Am Soc Nephrol 13: 2133-2139, 2002
4. Betjes MG, van Agteren M: Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution. Nephrol Dial Transplant 19: 1546-1551, 2004
5. Weijmer MC, van den Dorpel MA, Van de Ven PJ, ter Wee PM, van Geelen JA, Groeneveld JO, van Jaarsveld BC, Koopmans MG, le Poole CY, Schrander-Van der Meer AM, Siegert CE, Stas KJ; CITRATE Study Group: Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients. J Am Soc Nephrol 16: 2769-2777, 2005
6. Kim SH, Song KI, Chang JW, Kim SB, Sung SA, Jo SK, Cho WY, Kim HK: Prevention of uncuffed hemodialysis catheter-related bacteremia using an antibiotic lock technique: A prospective, randomized clinical trial. Kidney Int 69: 161-164, 2006
7. Saxena AK, Panhotra BR, Sundaram DS, Al-Hafiz A, Naguib M, Venkateshappa CK, Abu-Oun BA, Hussain SM, Al-Ghamdi AA: Tunneled catheters' outcome optimization among diabetics on dialysis through antibiotic-lock placement. Kidney Int 70: 1629-1635, 2006
8. Finelli L, Miller JT, Tokars JI, Alter MJ, Arduino MJ: National surveillance of dialysis-associated diseases in the United States, 2002. Semin Dial 18: 52-61, 2005
9. Klevens RM, Tokars JI, Andrus M: Electronic reporting of infections associated with hemodialysis. Nephrol News Issues 19: 37-38, 43, 2005
10. Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, Striker G: The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med 330: 877-884, 1994
11. Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, Mujais S; Mexican Nephrology Collaborative Study Group: Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 13: 1307-1320, 2002
12. Cheung AK Levin NW GT, Agodoa L, Bailey J, Agodoa L, Bailey J, Beck G, Clark W, Levey AS, Leypoldt JK, Ornt DB, Rocco MV, Schulman G, Schwab S, Teehan B, Eknoyan G: Effects of high-flux hemodialysis on clinical outcomes: Results of the HEMO study. J Am Soc Nephrol 14: 3251-3263, 2003
13. Warmer C, Krane V, Marz W, Olschewski M, Mann JF, Ruf G, Ritz E; German Diabetes and Dialysis Study Investigators: Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 353: 238-248, 2005 [published erratum, appears in N Engl J Med 353: 1640, 2005]
14. Agharazii M, Plamondon I, Lebel M, Douville P, Desmeules S: Estimation of heparin leak into the systemic circulation after central venous catheter heparin lock. Nephrol Dial Transplant 20: 1238-1240, 2005
15. FDA issues warning on tricitrasol dialysis catheter anticoagulant. Available at http://www.fda.gov/bbs/topics/ANSWERS/ANS01009.html. Accessed July 26, 2007
16. Fluck R, McIntyre C, Taal M: A one-year experience single center with antibiotic locking for tunneled venous catheters [Abstract]. J Am Soc Nephrol 17: SA-P0069, 2006
17. Zhang P, Zhang W, He Q, Yuan J, Xie W, Jiang W, Jiang H, Chen J: A randomized controlled study on prevention of cuff-tunneled catheter related bacteremia with gentamicin-heparin lock solution: The metaphase result[Abstract]. J Am Soc Nephrol 17: SA-PO073, 2006
18. Feely T, Coppley A, Bleyer AJ: Catheter lock solutions to prevent blood stream infections in high risk HD patients. Am J Nephrol 27: 24-29, 2007
19. Nori US, Manoharan A, Yee J, Besarab A: Comparison of low-dose gentamicin with minocycline as catheter lock solutions in the prevention of catheter-related bacteremia. Am J Kidney Dis 48: 596-605, 2006
20. Saxena AK, Panhotra BR, Naguib M: Sudden irreversible sensory-neural hearing loss in a patient with diabetes receiving amikacin as an antibiotic-heparin lock. Pharmacotherapy 22: 105-108, 2002
21. Stryjewski ME, Szczech LA, Benjamin DK, Inrig JK, Kanafani ZA, Engemann JJ, Chu VH, Joyce MJ, Reller LB, Corey GR, Fowler VG: Use of vancomycin or first-generation cephalosporins for treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia. Clin Infect Dis 44: 190-196, 2007
22. Bleyer AJ, Mason L, Russell GB, Raad II, Sherertz RJ: A randomized, controlled trial of a new vascular catheter flush solution (minocycline-EDTA) in temporary hemodialysis access. Infect Control Hosp Epidemiol 26: 520-524, 2005
23. Raad I, Buzaid A, Rhyne J, Hachem R, Darouiche R, Safar H, Albitar M, Sherertz RJ: Minocycline and ethylenediaminetetraacetate for the prevention of recurrent vascular catheter infections. Clin Infect Dis 25: 149-151, 1997
24. Nissenson AR: Influence of industry on renal guideline development commentary: Keeping our eye on the ball and improving chronic kidney disease patient outcomes. Clin J Am Soc Nephrol 2: 205-206, 2007
25. Warren DK, Zack JE, Mayfield JL, Chen A, Prentice D, Fraser VJ, Kollef MH: The effect of an education program on the incidence of central venous catheter-associated bloodstream infection in a medical ICU. Chest 126: 1612-1618, 2004
26. Powe NR, Jaar B, Furth SL, Hermann J, Briggs W: Septicemia in dialysis patients: Incidence, risk factors, and prognosis. Kidney Int 55: 1081-1090, 1999
27. Nassar GM, Ayus JC: Infectious complications of the hemodialysis access. Kidney Int 60: 1-13, 2001
28. Saxena AK, Panhotra BR: The impact of catheter-restricted filling with cefotaxime and heparin on the lifespan of temporary hemodialysis catheters: A case controlled study. J Nephrol 18: 755-763, 2005
29. Chiou PF, Chang C, Wen YK, Yang Y: Antibiotic lock technique reduces the incidence of temporary catheter-related infections. Clin Nephrol 65: 419-422, 2006
30. Wang A, Athan E, Pappas PA, Fowler VG, Olaison L, Pare C, Almirante B, Munoz P, Rizzi M, Naber C, Logar M, Tattevin P, larussi DL, Selton-Suty C, Jones SB, Casabe J, Morris A, Corey GR, Cabell CH, International Collaboration on Endocarditis-Prospective Cohort Study Investigators: Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA 297: 1354-1361, 2007
31. Post JJ, Alexopoulos C, Fewtrell C, Giles R, Jones PD: Outcome after complete percutaneous removal of infected pacemaker systems and implantable cardiac defibrillators. Intern Med J 36: 790-792, 2006
32. Chamis AL, Peterson GE, Cabell CH, Corey GR, Sorrentino RA, Greenfield RA, Ryan T, Reller LB, Fowler VG: Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter-defibrillators. Circulation 104: 1029-1033, 2001
33. National Kidney Foundation: Clinical practice guidelines and clinical practice recommendations for 2006 updates: Hemodialysis adequacy, peritoneal dialysis adequacy and vascular access. Am J Kidney Dis 48 [Suppl 1]. Sl-S322, 2006
34. O'Grady N, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, Masur H, McCormick RD, Mermel LA, Pearson ML, Raad II, Randolph A, Weinstein RA: Guidelines for the prevention of intravascular catheter-related infections. MMWR Recomm Rep 51: 1-26, 2002